Skip to main content

Johnson David Michael's Form 4 filing

Aura Biosciences, Inc. (AURA) · filed Jun 14, 2022

Accession no.
0000899243-22-022456
Filed
Jun 14, 2022
Trade date
Jun 10-13, 2022
Filing delay
4 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 6 non-derivative transactions and 0 derivative transactions. Open-market purchases total $716.3K. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Johnson David MichaelCIK 0001808098Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jun 10, 2022Common StockPPurchaseAcquired+3,000$15.04+$45,1203,000Indirect
Jun 10, 2022Common StockPPurchaseAcquired+3,000$15.04+$45,1203,000Indirect
Jun 10, 2022Common StockPPurchaseAcquired+10,000$15.04+$150,40010,000Direct
Jun 13, 2022Common StockPPurchaseAcquired+7,000$13.99+$97,93010,000Indirect
Jun 13, 2022Common StockPPurchaseAcquired+7,000$13.99+$97,93010,000Indirect
Jun 13, 2022Common StockPPurchaseAcquired+20,000$13.99+$279,80030,000Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)